You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-649-ESGO Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-649-ESGO Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

AbstractFullPdf
Oct 2022200
Nov 20221401
Dec 20223307
Jan 20231801
Feb 20231001
Mar 2023800
Apr 20231201
May 2023400
Jun 2023400
Jul 2023805
Aug 2023603
Oct 2023401
Nov 20231002
Dec 2023902
Jan 20245201
Feb 20241804
Mar 2024806
Apr 2024400
Total224035